Article: Claritin rushed to drugstore shelves

Claritin, the blockbuster allergy medicine, will hit retail shelves next week with a new identity as an over-the-counter drug. That arrival represents a major development for allergy sufferers. The Claritin story also reflects widespread tensions over rising health care costs. Claritin's transition is a turning point for the popular drug, whose sales were fueled by new consumer advertising, then challenged by a defiant insurance company worried about pharmaceutical spending. That conflict surfaced at the Food and Drug Administration, which last week approved allowing the nonsedating antihistamine to be sold without a prescription. The Claritin switch also involved a looming patent ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!